Clinical Trial Update: 68Ga-PSMA PET/CT in Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update on 68Ga-PSMA PET/CT in prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA PET/CT (68Ga-PSMA PET/CT imaging agent)

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED